Evidence map›Paper›PMID 24448480›Full record

ArticleNucleus (Austin, Tex.)

Label-free mass spectrometry exploits dozens of detected peptides to quantify lamins in wildtype and knockdown cells.

Joe Swift, Takamasa Harada, Amnon Buxboim, Jae-Won Shin, Hsin-Yao Tang, David W Speicher, Dennis E Discher

Open access · goldAbstract readComment
In one paragraph

Article in Nucleus (Austin, Tex.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Nuclear lamins and neurobiology.Molecular and cellular biology · 2014
    Review
  7. Review
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Joe SwiftMolecular & Cell Biophysics Laboratory, University of Pennsylvania; Philadelphia PA USA; Center for Systems and Computational Biology; Wistar Institute; Philadelphia PA USA.
Takamasa HaradaMolecular & Cell Biophysics Laboratory, University of Pennsylvania; Philadelphia PA USA.
Amnon BuxboimMolecular & Cell Biophysics Laboratory, University of Pennsylvania; Philadelphia PA USA.
Jae-Won ShinMolecular & Cell Biophysics Laboratory, University of Pennsylvania; Philadelphia PA USA.
Hsin-Yao TangCenter for Systems and Computational Biology; Wistar Institute; Philadelphia PA USA.
David W SpeicherCenter for Systems and Computational Biology; Wistar Institute; Philadelphia PA USA.
Dennis E DischerMolecular & Cell Biophysics Laboratory, University of Pennsylvania; Philadelphia PA USA; Center for Systems and Computational Biology; Wistar Institute; Philadelphia PA USA.
University of Pennsylvania · USCenter for Systems Biology · USPhiladelphia University · USThe Wistar Institute · US

Funding

Tumor Microenvironment and MetastasisP30CA010815 · NCI · WISTAR INSTITUTE · PI Luis J Montaner · 1985 to 2026
$75.9M
Institutional Clinical and Translational Science AwardUL1TR000003 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2012 to 2015
$38.9M
YEAST MEMBRANE CYTOSKELETONP01DK032094 · NIDDK · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI NARLA, MOHANDAS · 1987 to 2021
$26.7M
Membrane Proteins of Normal and Abnormal Red CellsR01HL038794 · NHLBI · WISTAR INSTITUTE · PI SPEICHER, DAVID W. · 1987 to 2013
$5.1M
SPECTRIN EXTENSIBILITY and CD47 CONNECTIONS &FUNCTIONR01HL062352 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI DISCHER, DENNIS E. · 1999 to 2012
$3.3M
Carrier Shape Matters: Filomicelles, Long-circulation, and the EPR effectR01EB007049 · NIBIB · UNIVERSITY OF PENNSYLVANIA · PI DISCHER, DENNIS E. · 2006 to 2014
$2.8M
NCATS NIH HHS 8UL1TR000003NCATS NIH HHS UL1 TR000003NCI NIH HHS CA010815NCI NIH HHS P30 CA010815NHLBI NIH HHS HL038794NHLBI NIH HHS R01 HL038794NHLBI NIH HHS R01 HL062352NHLBI NIH HHS R01HL062352NIBIB NIH HHS R01 EB007049NIBIB NIH HHS R01EB007049NIDDK NIH HHS P01 DK032094NIDDK NIH HHS P01DK032094
6 · The paper itself

Abstract

Label-free quantitation and characterization of proteins by mass spectrometry (MS) is now feasible, especially for moderately expressed structural proteins such as lamins that typically yield dozens of tryptic peptides from tissue cells. Using standard cell culture samples, we describe general algorithms for quantitative analysis of peptides identified in liquid chromatography tandem mass spectrometry (LC-MS/MS). The algorithms were foundational to the discovery that the absolute stoichiometry of A-type to B-type lamins scales with tissue stiffness (Swift et al., Science 2013). Isoform dominance helps make sense of why mutations and changes with age of mechanosensitive lamin-A,C only affect "stiff" tissues such as heart, muscle, bone, or even fat, but not brain. A Peak Ratio Fingerprinting (PRF) algorithm is elaborated here through its application to lamin-A,C knockdown. After demonstrating the large dynamic range of PRF using calibrated mixtures of human and mouse lysates, we validate measurements of partial knockdown with standard cell biology analyses using quantitative immunofluorescence and immunoblotting. Optimal sets of MS-detected peptides as determined by PRF demonstrate that the strongest peptide signals are not necessarily the most reliable for quantitation. After lamin-A,C knockdown, PRF computes an invariant set of "housekeeping" proteins as part of a broader proteomic analysis that also shows the proteome of mesenchymal stem cells (MSCs) is more broadly perturbed than that of a human epithelial cancer line (A549s), with particular variation in nuclear and cytoskeletal proteins. These methods offer exciting prospects for basic and clinical studies of lamin-A,C as well as other MS-detectable proteins.

Indexed as

Cell DifferentiationElasticityOsteogenesisStress, MechanicalAnimalsHumansLamin Type AMesenchymal Stem CellsLamin Type Aisoformlabel-freelaminmass spectrometrynormalizationproteomicsspliceoform

Identifiers

PMID24448480
PMCPMC3925690
OpenAlexW2033175421

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.